missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Human KIR3DL1 APC-conjugated Antibody, R&D Systems™
Mouse Monoclonal Antibody has been used in 4 publications
Marca: R&D Systems FAB1225A-100
Este artículo no se puede devolver.
Vea la política de devoluciones
Descripción
KIR3DL1 Monoclonal specifically detects KIR3DL1 in Human samples. It is validated for Flow Cytometry.
Especificaciones
KIR3DL1 | |
Monoclonal | |
APC | |
Supplied in a saline solution containing BSA and Sodium Azide. with Sodium Azide | |
KIR3DL1 | |
Human KIR3DL1-expressing NK cell clone | |
100 Tests | |
Primary | |
Detects human KIR3DL1. Did not cross-react with other KIR family members when tested against a series of KIR-expressing BaF/3 tansfectants (KIR2DL1, KIR2DL2, KIR2DL3, KIR2DL4, KIR2DS1, KIR2DS2, KIR2DS3, KIR2DS4, and KIR3DL2; Bakker, A.B.H. et al. (1998) J. Immunol. 160:5239). | |
Protect from light. Do not freeze. 12 months from date of receipt, 2 to 8 degreesC as supplied. | |
IgG1 |
Flow Cytometry | |
DX9 | |
Flow Cytometry 10 uL/10^6 cells | |
AMB11, CD158 antigen-like family member E, CD158E, CD158e antigen, CD158e1, CD158e1/2, CD158e2, cl-11, cl-2, HLA-BW4-specific inhibitory NK cell receptor, killer cell immunoglobulin-like receptor 3DL1, killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail1,nkat3, killer Ig receptor, KIR antigen 3DL1, KIR3DL1/S1, KIR3DS1, MGC119726, MGC119728, MGC126589, MGC126591, MHC class I NK cell receptor, Natural killer-associated transcript 3, Nkat3, NKAT-3, NKAT3KIR, NKB1, NKB1B, NKB1CD158E1, NK-receptor, p70 killer cell inhibitory receptor, p70 natural killer cell receptor clones CL-2/CL-11, p70 NK receptor CL-2/CL-11 | |
Mouse | |
Protein A or G purified from hybridoma culture supernatant | |
RUO | |
3811 | |
Human | |
Purified |
Corrección del contenido de un producto
Proporcione sus comentarios sobre el contenido del producto rellenando el siguiente formulario.
Título del producto
Human KIR3DL1 APC-conjugated Antibody, R&D Systems™ > 100 Tests; APC
¿Detecta una oportunidad de mejora?Comparta una corrección de contenido